191 related articles for article (PubMed ID: 33257663)
1. Lkb1 suppresses amino acid-driven gluconeogenesis in the liver.
Just PA; Charawi S; Denis RGP; Savall M; Traore M; Foretz M; Bastu S; Magassa S; Senni N; Sohier P; Wursmer M; Vasseur-Cognet M; Schmitt A; Le Gall M; Leduc M; Guillonneau F; De Bandt JP; Mayeux P; Romagnolo B; Luquet S; Bossard P; Perret C
Nat Commun; 2020 Nov; 11(1):6127. PubMed ID: 33257663
[TBL] [Abstract][Full Text] [Related]
2. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
3. Oleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic Model.
Ren T; Ma A; Zhuo R; Zhang H; Peng L; Jin X; Yao E; Yang L
J Pharmacol Exp Ther; 2020 Apr; 373(1):81-91. PubMed ID: 32024803
[TBL] [Abstract][Full Text] [Related]
4. The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver.
Patel K; Foretz M; Marion A; Campbell DG; Gourlay R; Boudaba N; Tournier E; Titchenell P; Peggie M; Deak M; Wan M; Kaestner KH; Göransson O; Viollet B; Gray NS; Birnbaum MJ; Sutherland C; Sakamoto K
Nat Commun; 2014 Aug; 5():4535. PubMed ID: 25088745
[TBL] [Abstract][Full Text] [Related]
5. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
Shaw RJ; Lamia KA; Vasquez D; Koo SH; Bardeesy N; Depinho RA; Montminy M; Cantley LC
Science; 2005 Dec; 310(5754):1642-6. PubMed ID: 16308421
[TBL] [Abstract][Full Text] [Related]
6. Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids.
Martino MR; Gutiérrez-Aguilar M; Yiew NKH; Lutkewitte AJ; Singer JM; McCommis KS; Ferguson D; Liss KHH; Yoshino J; Renkemeyer MK; Smith GI; Cho K; Fletcher JA; Klein S; Patti GJ; Burgess SC; Finck BN
Cell Rep; 2022 Apr; 39(4):110733. PubMed ID: 35476997
[TBL] [Abstract][Full Text] [Related]
7. [From cancer to diabetes treatment : the tumor suppressor LKB1 as a new pharmacological target].
Foretz M; Guigas B; Viollet B
Med Sci (Paris); 2006 Apr; 22(4):348-50. PubMed ID: 16597397
[No Abstract] [Full Text] [Related]
8. Amino acid and protein metabolism in diabetes mellitus.
Felig P; Wahren J; Sherwin R; Palaiologos G
Arch Intern Med; 1977 Apr; 137(4):507-13. PubMed ID: 403871
[TBL] [Abstract][Full Text] [Related]
9. Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model.
Amrutkar M; Cansby E; Chursa U; Nuñez-Durán E; Chanclón B; Ståhlman M; Fridén V; Mannerås-Holm L; Wickman A; Smith U; Bäckhed F; Borén J; Howell BW; Mahlapuu M
Diabetes; 2015 Aug; 64(8):2791-804. PubMed ID: 25845663
[TBL] [Abstract][Full Text] [Related]
10. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
[TBL] [Abstract][Full Text] [Related]
11. Deletion of Lkb1 in adult mice results in body weight reduction and lethality.
Shan T; Xiong Y; Kuang S
Sci Rep; 2016 Nov; 6():36561. PubMed ID: 27824128
[TBL] [Abstract][Full Text] [Related]
12. Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1.
Yan H; Yang W; Zhou F; Li X; Pan Q; Shen Z; Han G; Newell-Fugate A; Tian Y; Majeti R; Liu W; Xu Y; Wu C; Allred K; Allred C; Sun Y; Guo S
Diabetes; 2019 Feb; 68(2):291-304. PubMed ID: 30487265
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathophysiology of hepatic glucose production.
Sharabi K; Tavares CD; Rines AK; Puigserver P
Mol Aspects Med; 2015 Dec; 46():21-33. PubMed ID: 26549348
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Mitochondrial Pyruvate Carrier 1 Is Required for Efficient Regulation of Gluconeogenesis and Whole-Body Glucose Homeostasis.
Gray LR; Sultana MR; Rauckhorst AJ; Oonthonpan L; Tompkins SC; Sharma A; Fu X; Miao R; Pewa AD; Brown KS; Lane EE; Dohlman A; Zepeda-Orozco D; Xie J; Rutter J; Norris AW; Cox JE; Burgess SC; Potthoff MJ; Taylor EB
Cell Metab; 2015 Oct; 22(4):669-81. PubMed ID: 26344103
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone-induced Krüppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia.
Cui A; Fan H; Zhang Y; Zhang Y; Niu D; Liu S; Liu Q; Ma W; Shen Z; Shen L; Liu Y; Zhang H; Xue Y; Cui Y; Wang Q; Xiao X; Fang F; Yang J; Cui Q; Chang Y
J Clin Invest; 2019 Apr; 129(6):2266-2278. PubMed ID: 31033478
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
[TBL] [Abstract][Full Text] [Related]
17. The KLF14 transcription factor regulates hepatic gluconeogenesis in mice.
Wang L; Tong X; Gu F; Zhang L; Chen W; Cheng X; Xie L; Chang Y; Zhang H
J Biol Chem; 2017 Dec; 292(52):21631-21642. PubMed ID: 29123026
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte Rap1a contributes to obesity- and statin-associated hyperglycemia.
Wang Y; Spolitu S; Zadroga JA; Sarecha AK; Ozcan L
Cell Rep; 2022 Aug; 40(8):111259. PubMed ID: 36001955
[TBL] [Abstract][Full Text] [Related]
19. Genetic ablation of Fas-activated serine/threonine kinase ameliorates obesity-related hepatic glucose and lipid metabolic disorders via sirtuin-1 signaling.
Zhang F; Pei J; Chen X
Biochem Biophys Res Commun; 2020 Sep; 529(4):1066-1072. PubMed ID: 32819566
[TBL] [Abstract][Full Text] [Related]
20. LKB1: a sweet side to Peutz-Jeghers syndrome?
Carling D
Trends Mol Med; 2006 Apr; 12(4):144-7. PubMed ID: 16530014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
